title: Recurrence of retinopathy of prematurity following bevacizumab monotherapy: is it only the tip of the iceberg?
authors.forename: Kamiar
authors.initials: K
authors.lastname: Mireskandari
authors.forename: Gillian G W
authors.initials: GG
authors.lastname: Adams
authors.forename: Nasrin N
authors.initials: NN
authors.lastname: Tehrani
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D006801:Humans; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized